Long-Term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: a 4-Year, Phase 3, Open-Label Study

Dellon, E. S., Katzka, D. A., Mukkada, V. A., Collins, M. H., Falk, G. W., Richmond, C. A., Terreri, B., Thakur, M., Boules, M., Goodwin, B., & Hirano, I. (2025). Long-Term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: a 4-Year, Phase 3, Open-Label Study. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.12.024
Authors:
Evan S Dellon
David A Katzka
Vincent A Mukkada
Margaret H Collins
Gary W Falk
Camilla A Richmond
Brian Terreri
Manoj Thakur
Mena Boules
Bridgett Goodwin
Ikuo Hirano
Affiliated Authors:
David A Katzka
Author Keywords:
budesonide oral suspension
eosinophilic esophagitis
long-term efficacy
long-term safety
Publication Type:
Article
Unique ID:
10.1016/j.cgh.2024.12.024
PMID:
Publication Date:
Data Source:
PubMed

Record Created: